Biotechnology - Biotechnology

Filter

Current filters:

Biotechnology

Popular Filters

1 to 25 of 2433 results

Claritas Genomics appoints Patrick Terry as chief commercial officer

Claritas Genomics appoints Patrick Terry as chief commercial officer

18-12-2014

Genetic diagnostic lab, Claritas Genomics, has appointed Patrick Terry as chief commercial officer.

BiotechnologyBoardroomClaritas GenomicsGenomicsPatrick Terry

Amgen reveals Blincyto price as $178,000 per course

Amgen reveals Blincyto price as $178,000 per course

18-12-2014

USA-based Amgen has revealed its intended pricing for its immunotherapy Blincyto (blinatumomab), which…

AmgenBiotechnologyBlincytoOncologyPricingUSA

Report: Colorectal cancer market in Asia-Pacific region set to reach $3 billion by 2020

Report: Colorectal cancer market in Asia-Pacific region set to reach $3 billion by 2020

18-12-2014

The Colorectal Cancer (CRC) therapeutics market in Asia-Pacific (APAC) is set to increase in value, from…

AmgenAsia-PacificBiotechnologyDanDrit BiotechEli LillyMarkets & MarketingMelCancerVacOncologyVectibixXBiotechXilonix

X-Chem licenses second cardiovascular drug discovery program to Bayer

X-Chem licenses second cardiovascular drug discovery program to Bayer

18-12-2014

Privately-held biotech firm X-Chem has licensed a second drug discovery program to German pharma major…

BayerBiotechnologyCardio-vascularLicensingX-Chem

Celgene appoints Marie-France Tschudin and Stefano Portolano to EMEA team

Celgene appoints Marie-France Tschudin and Stefano Portolano to EMEA team

18-12-2014

US biotech company Celgene Corp has made two appointments to its EMEA team.

BiotechnologyBoardroomCelgene CorpCelgene Corp.Stefano Portolano

Emergent BioSolutions acquires EV-035 series of molecules from Evolva Holding

Emergent BioSolutions acquires EV-035 series of molecules from Evolva Holding

17-12-2014

Biopharma company Emergent BioSolutions has acquired the EV-035 series of molecules from Evolva Holding.

Antibiotics and Infectious diseasesBiotechnologyEmergent BioSolutionsEvolvaLicensingResearchUSA

Novartis venture fund leads $34 million financing for Annexon Bioscience

Novartis venture fund leads $34 million financing for Annexon Bioscience

17-12-2014

USA-based Annexon Bioscience says it has closed a $34 million Series A-1 to support the development of…

Annexon BioscienceANX005BiotechnologyFinancialNeurologicalNovartis

CMC Biologics and OncoSynergy link on Ebola drug development and manufacture

CMC Biologics and OncoSynergy link on Ebola drug development and manufacture

16-12-2014

Denmark and USA-based contract manufacturers CMC Biologics and US biopharma start-up OncoSynergy have…

Anti-viralsBiotechnologyCMC BiologicsOncoSynergyOS2966ProductionResearchTropical diseases

Neovacs' Phase IIb study of TNF-Kinoid in rheumatoid arthritis fails to meet primary endpoints

Neovacs' Phase IIb study of TNF-Kinoid in rheumatoid arthritis fails to meet primary endpoints

16-12-2014

French autoimmune specialist Neovacs says that its Phase IIb trial of TNF-Kinoid in rheumatoid arthritis…

BiotechnologyFranceImmunologicalsNeovacsResearchTNF-Kinoid

Curie-Cancer renews research partnership with GamaMabs Pharma for ovarian cancer drug

Curie-Cancer renews research partnership with GamaMabs Pharma for ovarian cancer drug

16-12-2014

Curie-Cancer, the body responsible for developing Institut Curie’s industry partnership activities,…

BiotechnologyFranceGamaMabs PharmaOncologyResearch

Anthera Pharma licenses Japan rights for blisibimod to Zenyaku Kogyo

Anthera Pharma licenses Japan rights for blisibimod to Zenyaku Kogyo

16-12-2014

US development-stage biophama company Anthera Pharmaceuticals has entered into an exclusive licensing…

AmgenAnthera PharmaceuticalsBiotechnologyblisibimodJapanLicensingOncologyZenyaku Kogyo

Sophiris Bio shares slide on Phase III results of PRX302

Sophiris Bio shares slide on Phase III results of PRX302

16-12-2014

Biotech company Sophiris Bio saw shares in the company fall up to almost 80% following an announcement…

BiotechnologyMen's HealthPRX302ResearchSophiris Bio

Astellas Venture Management invests in Crescendo's Humabody antibody fragment project

Astellas Venture Management invests in Crescendo's Humabody antibody fragment project

16-12-2014

UK-based antibody therapeutics specialist Crescendo Biologics has received another equity investment…

BiotechnologyBusiness FinanceCrescendo BiologicsOncologyUK

New $11 million Biotech Innovation Hub opens in Birmingham, UK

New $11 million Biotech Innovation Hub opens in Birmingham, UK

16-12-2014

A new biomedical laboratory, the Biomedical Innovation Hub (the BioHub) has opened in Birmingham, UK.

BiotechnologyBirminghamResearchUKUnited Kingdom

Sorrento to partner with Nantworks founder Patrick Soon-Shiong on immunomodulatory antibodies

Sorrento to partner with Nantworks founder Patrick Soon-Shiong on immunomodulatory antibodies

15-12-2014

Oncology specialist Sorrento Therapeutics has entered into a binding agreement with medical technology…

BiotechnologyLicensingOncologyResearchSorrento TherapeuticsUSA

Genentech files NDA for cobimetinib with Zelboraf in advanced melanoma

Genentech files NDA for cobimetinib with Zelboraf in advanced melanoma

15-12-2014

Genentech, the US biotech subsidiary of Swiss Pharma major Roche Group, has submitted a New Drug Application…

BiotechnologycobimetinibExelixisGenentechOncologyRegulationRocheUSAZelboraf

Gilead appoints Philippe Bishop as senior vice president of hematology and oncology therapeutics

Gilead appoints Philippe Bishop as senior vice president of hematology and oncology therapeutics

15-12-2014

US biotech major Gilead Sciences has appointed Philippe Bishop as senior vice president of hematology…

BiotechnologyBoardroomGilead SciencesHematologyOncologyUSA

Ignyta and Nerviano amend license accord on entrectinib

Ignyta and Nerviano amend license accord on entrectinib

15-12-2014

US oncology focused biotech firm Ignyta has agreed to an amendment to its license agreement with Italy’s…

BiotechnologyentrectinibIgnytaLicensingNerviano Medical SciencesOncologyRXDX-101

Zealand Pharma's senior vice president Arvind Hundal steps down

Zealand Pharma's senior vice president Arvind Hundal steps down

15-12-2014

Denmark-based biotech company Zealand Pharma announced today that senior vice president and chief business…

Arvind HundalBiotechnologyBoardroomDenmarkZealand Pharma

Co-founder Joost Holthuis replaces founder as chief executive amid $7 million financing round

Co-founder Joost Holthuis replaces founder as chief executive amid $7 million financing round

15-12-2014

The co-founder of Dutch nanomedicine company Cristal Therapeutics, Joost Holthuis, has succeeded its…

BioGeneration VenturesBiotechnologyBoardroomCristal TherapeuticsNetherlands

NetScientific invests in PDS Biotechnology

NetScientific invests in PDS Biotechnology

15-12-2014

UK-based life sciences investor NetScientific has made an undisclosed investment in privately-held US…

Antibiotics and Infectious diseasesBiotechnologyMergers & AcquisitionsNetScientificOncologyPDS BiotechnologyUK

Plans unveiled for Singapore’s biologics manufacturing industry

Plans unveiled for Singapore’s biologics manufacturing industry

13-12-2014

The Singapore Workforce Development Agency (WDA), Singapore Economic Development Board (EDB) and Biopharmaceutical…

AbbVieAmgenBaxterBiotechnologyGlaxoSmithKlineLonzaNovartisProductionRocheSingapore

Valneva and BliNK Therapeutics launch new biotech company

Valneva and BliNK Therapeutics launch new biotech company

12-12-2014

France-based biotech firm Valneva and privately-held UK company BliNK Therapeutics have created a private…

BiotechnologyBliNK BiomedicalBliNK TherapeuticsFinancialFranceMergers & AcquisitionsUKValneva

Sosei to acquire Japanese peptide technology company Jitsubo

Sosei to acquire Japanese peptide technology company Jitsubo

12-12-2014

Japanese biopharma company Sosei says its board of directors has resolved to acquire existing shares…

BiotechnologyJapanJitsuboMergers & AcquisitionsSosei

1 to 25 of 2433 results

Back to top